Unlock instant, AI-driven research and patent intelligence for your innovation.

Conditionally active biological proteins

A conditional activity and biological protein technology, applied in the field of protein evolution and activity, can solve problems such as protein instability

Inactive Publication Date: 2017-02-22
BIOATLA INC
View PDF101 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, there are examples of natural mutations that render proteins unstable under normal working conditions such as the wild-type temperature activity of the molecule

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Conditionally active biological proteins
  • Conditionally active biological proteins

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0358] Monoclonal antibodies can be produced using any technique that provides antibodies produced by continuous cell line culture. Examples include hybridoma technology, trisomy hybridoma technology, human B-cell hybridoma technology and Epstein-Barr virus hybridoma technology (see for example, Cole (1985), Monoclonal Antibodies and Cancer Therapy (Monoclonal Antibodies and Cancer Therapy), Alan R . Liss, Inc., pp. 77-96).

[0359] Techniques described for the production of single chain antibodies (see eg, US Pat. No. 4,946,778) can be adapted to produce single chain antibodies directed against polypeptides of the invention. Alternatively, transgenic mice expressing humanized antibodies against these polypeptides or fragments thereof can be used. Antibodies raised against polypeptides of the invention can be used to screen for similar polypeptides (eg, enzymes) from other organisms and samples. In these techniques, polypeptides from an organism are contacted with antibodies...

Embodiment 1

[0434] Example 1: Overview of Multiwall Assays (eg, 96-well Assays) for Temperature Abruptions

[0435] Fluorescent substrates are added to each well of the multi-wall plate for an appropriate time at either wild-type or a new lower reaction temperature (eg, 37°C or 25°C as described above). Fluorescence is detected by measuring fluorescence in a fluorescent microplate reader under appropriate excitation and emission spectra (eg, 320 nm excitation / 405 nm emission). Measure relative fluorescence units (RFU). Supernatants obtained from wild-type molecule and plasmid / vector transformed cells served as positive and negative controls. Duplicate reactions were performed for each sample, each reaction temperature, and positive and negative controls.

[0436] are active at lower temperatures (e.g., mutants are active at 25°C), and are less active at wild-type temperatures (e.g., 10%, 20%, 30%, 40% or more active at 37°C) more), and thus a mutant with an activity ratio greater than ...

Embodiment 2

[0437] Example 2: Overview of Different Assays (eg, 14-mL Assay) for Determining Activity of Temperature Mutants

[0438] Mutants of identified major temperature-sensitive shoots were expressed in 14 ml culture tubes and their enzymatic activities were assayed at wild-type (eg, 37°C) and lower temperatures (eg, 25°C). Proteins were expressed and purified as described above for the multiwall method, except expression was done in a different format (14 ml tubes) rather than the multiwall (96-well plate) format.

[0439] The supernatant of each mutant is transferred to a multi-walled plate, such as a 96-well plate. Fluorescent substrate was added to each tube at the indicated reaction temperature (wild type, lower temperature) for the desired period of time. Wild-type molecules were used as positive controls and supernatants from cells transformed with vector only were used as negative controls. Fluorescence is detected by measuring fluorescence in a fluorescent microplate read...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This disclosure relates to a method of generating conditionally active biologic proteins from wild type proteins, in particular therapeutic proteins, which are reversibly or irreversibly inactivated at some physiological conditions. For example, conditionally active biologic proteins are active in tumors, but virtually inactive at other body parts, or conditionally active antibodies capable of crossing blood-brain-barrier.

Description

technical field [0001] The present invention relates to the field of protein evolution and activity. Specifically, the present invention relates to preparing from wild-type proteins reversibly or irreversibly inactivated conditionally active biological proteins (conditionally active biological protein) under normal physiological conditions of wild-type, also relates to such conditionally active proteins and such conditionally active biological proteins the use of. Background technique [0002] There is a large literature describing the potential to evolve various properties of proteins, especially eg enzymes, to work stably under different conditions. For example, enzymes have evolved to be stable at higher temperatures, with altered activities. In the case of enhanced high temperature activity, most of this increase is due to the higher kinetic activity generally described in the Q10 law, estimated for enzymes as a doubling of their turnover rate for every 10°C increase i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/09C12Q1/68C07K16/00C07K16/46C07K19/00
CPCC12Q1/68C07K14/52C07K14/54C07K14/575C07K14/475C12N9/00C07K2319/00C07K2319/30C12N15/1058A61P35/00C07K16/00C07K16/46C12N15/09C12N15/102C07K16/468C12N15/1027G01N33/15C12N15/1031C07K16/28C07K2317/31C07K2317/52G01N33/6854G01N2333/705
Inventor 杰·M·肖特怀文·张格哈德·弗雷
Owner BIOATLA INC